Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.
dc.contributor.author | Weibel, Daniel | |
dc.contributor.author | Sturkenboom, Miriam | |
dc.contributor.author | Black, Steven | |
dc.contributor.author | de Ridder, Maria | |
dc.contributor.author | Dodd, Caitlin | |
dc.contributor.author | Bonhoeffer, Jan | |
dc.contributor.author | Vanrolleghem, Ann | |
dc.contributor.author | van der Maas, Nicoline | |
dc.contributor.author | Lammers, Gert Jan | |
dc.contributor.author | Overeem, Sebastiaan | |
dc.contributor.author | Gentile, Angela | |
dc.contributor.author | Giglio, Norberto | |
dc.contributor.author | Castellano, Vanesa | |
dc.contributor.author | Kwong, Jeffrey C | |
dc.contributor.author | Murray, Brian J | |
dc.contributor.author | Cauch-Dudek, Karen | |
dc.contributor.author | Juhasz, Diana | |
dc.contributor.author | Campitelli, Michael | |
dc.contributor.author | Datta, Alexandre N | |
dc.contributor.author | Kallweit, Ulf | |
dc.contributor.author | Huang, Wan-Ting | |
dc.contributor.author | Huang, Yu-Shu | |
dc.contributor.author | Hsu, Chung-Yao | |
dc.contributor.author | Chen, Hsi-Chung | |
dc.contributor.author | Giner-Soriano, Maria | |
dc.contributor.author | Morros, Rosa | |
dc.contributor.author | Gaig, Carles | |
dc.contributor.author | Tió, Ester | |
dc.contributor.author | Perez-Vilar, Silvia | |
dc.contributor.author | Diez-Domingo, Javier | |
dc.contributor.author | Puertas, Francisco Javier | |
dc.contributor.author | Svenson, Lawrence W | |
dc.contributor.author | Mahmud, Salaheddin M | |
dc.contributor.author | Carleton, Bruce | |
dc.contributor.author | Naus, Monika | |
dc.contributor.author | Arnheim-Dahlström, Lisen | |
dc.contributor.author | Pedersen, Lars | |
dc.contributor.author | DeStefano, Frank | |
dc.contributor.author | Shimabukuro, Tom T | |
dc.date.accessioned | 2018-11-19T09:34:17Z | |
dc.date.available | 2018-11-19T09:34:17Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment. 2018, 36 (41):6202-6211 Vaccine | en |
dc.identifier.issn | 1873-2518 | |
dc.identifier.pmid | 30122647 | |
dc.identifier.doi | 10.1016/j.vaccine.2018.08.008 | |
dc.identifier.uri | http://hdl.handle.net/10029/622224 | |
dc.description.abstract | In 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovalent pandemic H1N1 influenza (pH1N1) vaccine. To further assess a possible association and inform policy on future use of adjuvants, we conducted a multi-country study of narcolepsy and adjuvanted pH1N1 vaccines. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to Vaccine | en |
dc.title | Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment. | en |
dc.type | Article | en |
dc.identifier.journal | Vaccine 2018; 36(41):6202-11 | en |
html.description.abstract | In 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovalent pandemic H1N1 influenza (pH1N1) vaccine. To further assess a possible association and inform policy on future use of adjuvants, we conducted a multi-country study of narcolepsy and adjuvanted pH1N1 vaccines. |